Luminex Wins DOD Contract for up to $11.6M to Develop Biothreat Detection Instrument

Aug 10, 2012

|

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Thursday it has been awarded a contract by the US Department of Defense to develop a prototype instrument for the rapid detection of biothreat agents and patient response biomarkers that may indicate systemic disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

From Relatives to Suspects

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

Family Ties

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

This Week in Science

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

Time to Kick Back With Some Golf

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

Featured White Papers

Discovering Neuronal Cell Types

Highly Resolved Separation of DNA Fragments on the Fragment Analyzer

FEMTO Pulse Genomic DNA Sizing and Quality Control

xMAP Cookbook: A collection of methods and protocols for developing multiplex assays with xMAP Technology

Jun

19

Featured Webinar

RNA in situ Hybridization: The Next Generation of Immunohistochemistry?

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun

21

Featured Webinar

Evaluation, Implementation, and Validation of NGS Liquid Biopsy Assays

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.

Main menu